The Stem Cell and Gene Therapy Biological Testing market is no longer a niche sector but a vital pillar of the modern pharmaceutical industry. With a projected leap from USD 1,497.03 million in 2020 to over USD 4.5 billion by 2028, the market reflects the maturing landscape of advanced therapies. As we look through 2025, the focus will remain on scaling these tests to accommodate mass... https://www.databridgemarketresearch.com/reports/global-stem-cell-and-gene-therapy-biological-testing-market